RGS17 Human

Regulator of G-Protein Signaling 17 Human Recombinant
Cat. No.
BT12673
Source
E.coli.
Synonyms
Regulator of G-protein signaling 17, RGS-17, RGSZ2, hRGS17.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

RGS17 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 230 amino acids (1-210) and having a molecular mass of 26.5 kDa.
The RGS17 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
RGS17 is a GTPase activating protein (GAP) that negatively regulates G protein signaling. It binds to activated, GTP-bound G alpha subunits and accelerates the hydrolysis of GTP to GDP. This hydrolysis enables the G alpha subunits to reassociate with G beta/gamma subunits, forming inactive G protein heterotrimers and terminating signal transduction. RGS17 is particularly important in regulating signaling by mu opioid receptors and is implicated in the development of tolerance to opioid analgesics.
Description
Recombinant human RGS17 is produced in E. coli as a non-glycosylated polypeptide chain. It consists of 230 amino acids (residues 1-210) and has a molecular mass of 26.5 kDa. The protein includes a 20-amino acid His-tag at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Colorless, sterile filtered solution.
Formulation
The RGS17 solution is provided at a concentration of 1 mg/ml in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.1 M NaCl, 1 mM DTT, and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For longer-term storage, it is recommended to store the protein at -20°C. Adding a carrier protein, such as 0.1% HSA or BSA, is advisable for extended storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the RGS17 protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
Regulator of G-protein signaling 17, RGS-17, RGSZ2, hRGS17.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MRKRQQSQNE GTPAVSQAPG NQRPNNTCCF CWCCCCSCSC LTVRNEERGE NAGRPTHTTK MESIQVLEEC QNPTAEEVLS WSQNFDKMMK APAGRNLFRE FLRTEYSEEN LLFWLACEDL KKEQNKKVIE EKARMIYEDY ISILSPKEVS LDSRVREVIN RNLLDPNPHM YEDAQLQIYT LMHRDSFPRF LNSQIYKSFV ESTAGSSSES.

Product Science Overview

Structure and Function

RGS17 contains a conserved 120 amino acid motif known as the RGS domain and a cysteine-rich region . The primary function of RGS17 is to attenuate the signaling activity of G-proteins by binding to activated, GTP-bound G alpha subunits. It acts as a GTPase-activating protein (GAP), increasing the rate of conversion of GTP to GDP. This hydrolysis allows the G alpha subunits to bind G beta/gamma subunit heterodimers, forming inactive G-protein heterotrimers and thereby terminating the signal .

Expression and Localization

RGS17 is typically expressed in the human central nervous system but is also found in other tissues such as the buccal mucosa, tendon of biceps brachii, cartilage tissue, and pancreatic ductal cells . It is involved in various cellular components, including the cytoplasm, neuron projection, cell junction, synapse, membrane, nucleus, and cytoplasmic vesicle .

Biological Processes

RGS17 plays a role in several biological processes, including:

  • Positive regulation of GTPase activity
  • Negative regulation of signal transduction
  • Response to amphetamine
  • G protein-coupled receptor signaling pathway
Clinical Significance

RGS17 has been identified as a putative lung cancer susceptibility gene located on chromosome 6q in humans . It is overexpressed in lung and prostate cancers and is required for the maintenance of proliferation in lung tumor cell lines . Additionally, RGS17 plays a role in the termination of signaling by mu opioid receptors and the development of tolerance to opioid analgesic drugs .

Research and Therapeutic Potential

RGS17 has been extensively studied for its role in inhibiting μ-opioid, dopamine, and cannabinoid receptors in the central nervous system . An interesting function of RGS17 is its potential role as a redox transducer, mediated by the interaction of its cysteine-rich domain with nitric oxide to release zinc . This makes RGS17 a novel target for therapeutic interventions in various diseases, including cancer and neurological disorders .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.